Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Glucose-lowering Drugs
100%
Relative Risk
100%
Relative Benefit
100%
Potential Gains
25%
Glycemic Control
25%
Diabetes
25%
Pharmacological Therapy
25%
Vascular Disease
25%
Potential Risk
25%
Modified Release
25%
Diamicron
25%
Metabolic Control
25%
Diabetes Disease
25%
Cross-study Comparison
25%
Safety Issues
25%
Control Evaluation
25%
Therapeutic Decision-making
25%
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
25%
Veterans Affairs
25%
Absolute Rates
25%
Medicine and Dentistry
Diabetes
100%
Maturity Onset Diabetes of the Young
100%
Decision Making
33%
Cardiovascular Risk
33%
Glycemic Control
33%
Vascular Disease
33%
Gliclazide
33%
Controlled Release
33%
Action Study
33%
Metabolic Regulation
33%
Veterans Affairs
33%
Indapamide Plus Perindopril
33%
Diseases
33%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Cardiovascular Risk
50%
Vascular Disease
50%
Modified Release
50%
Gliclazide
50%
Indapamide Plus Perindopril
50%
Diseases
50%